MARATTO

article · Matrouh Journal of Veterinary Medicine/Matrouh Journal of Veterinary Medicine

Rutin: Chemical properties, Pharmacokinetic properties and Biological activities

202423 citationsOpen accessUniversity of Sadat City

In plain language

Rutin is a prominent plant-derived flavonoid and phytochemical with notable relevance in the pharmaceutical sector. An evaluation of existing evidence highlights its extensive range of therapeutic biological activities. These documented benefits include antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and antitumor actions, alongside protective capabilities for the liver, kidneys, nervous system, and testes. Despite these positive qualities and an established safety profile characteristic of herbal remedies, practical medicinal adoption remains constrained. The main barriers preventing its widespread clinical deployment are poor water solubility and low absorption within the body. Overcoming these specific pharmacological limitations requires dedicated strategies to enhance its pharmacokinetic profile, enabling its prospective development into effective therapeutic treatments in the near future.

Key takeaways

  • Rutin exhibits diverse biological actions, including antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and antitumor activities.
  • The compound demonstrates protective effects on the liver, kidneys, nervous system, and testes.
  • Clinical and medicinal applications of rutin are significantly restricted by poor solubility and low absorption.
  • Developing targeted strategies to enhance rutin's pharmacokinetic profile is essential for future therapeutic deployment.

Why it matters

Plant-derived compounds offer valuable pathways for discovering effective treatments for complex human ailments. Although rutin exhibits broad protective and therapeutic capacities across multiple bodily systems, chemical hurdles prevent the body from absorbing it effectively. Outlining these precise limitations provides researchers and drug developers with a clear roadmap to create modified formulations that render the compound medically functional.

Commercialisation angle

Rutin represents an opportunity for pharmaceutical developers targeting multiple therapeutic areas, including organ protection, diabetes, and oncology. The compound is at an early research stage because poor solubility and low absorption obstruct direct clinical translation. Commercial deployment depends on drug delivery specialists creating formulation strategies that significantly enhance its pharmacokinetic profile and systemic uptake.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Recently, due to their excellent safety history and potent therapeutic effects, medicinal plants have gained the interest of researchers. Herbal remedies have been utilized for centuries to both prevent and treat a variety of diseases. Flavonoids, among them, contain polyphenols, which are well known for having a wide range of beneficial medical effects. Rutin is Considered as one of the most important flavonoids and valuable phytochemicals in the pharmaceutical industry. The current study's objective was to evaluate rutin's advantages and disadvantages, utilizing the previously published researches. The pharmacokinetic properties and medical uses of this compound were investigated in details, with an emphasis on new findings, considering its potential relevance to numerous health benefits as antioxidant, hepatoprotective, nephroprotective, neuroprotective, anti-inflammatory, antimicrobial, antidiabetic, antitumor properties and testicular protective action. However, due to some drawbacks, like low absorption and poor solubility, its medicinal use is restricted. Furthermore, strategies to improve the pharmacokinetic profile of rutin are also suggested in light of its possible therapeutic use in the near future

Research topics

  • Natural Antidiabetic Agents Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/mjvm.2024.341806

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.